Improved survival of autologous stem cell transplantation in primary refractory and relapsed Hodgkin lymphoma in the brentuximab vedotin era — real-world data from Hungary

导出原文传递

翻译打印收藏纠错

作者： Kata,Husi ^[1] ; Roxána,Szabó ^[2] ; László Imre,Pinczés ^[3] ; Dóra,F?ldeák ^[4] ; Réka,Dudley ; árpád,Szomor ; Beáta,Koller ; László,Gopcsa ; árpád,Illés ; Zsófia,Miltényi

作者单位： Division of Hematology, Department of Internal Medicine, Faculty of Medicine,University of Debrecen ^[1] Division of Hematology, 2nd Department of Internal Medicine, Faculty of Medicine,University of ^[2] Division of Hematology, 1st Department of Internal Medicine, Faculty of Medicine,University of Pécs ^[3] Department of Hematology and Stem Cell Transplantation,Central Hospital of Southern Pest National ^[4]

关键词 Hodgkin lymphoma Autologous stem cell transplantation Brentuximab vedotin PET/CT Survival

发布时间 2023-10-24

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交